Edition:
India

People: Ensign Group Inc (ENSG.OQ)

ENSG.OQ on NASDAQ Stock Exchange Global Select Market

56.10USD
20 May 2019
Change (% chg)

-- (--)
Prev Close
$56.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
116,992
52-wk High
$57.25
52-wk Low
$33.99

Nackel, John 

Dr. John G. Nackel, Ph.D. is an Independent Director of The Ensign Group, Inc. Dr. Nackel has served as a member of our Board of Directors since his election to the Board in June 2008. He is currently the Chairman and Chief Executive Officer of Three-Sixty Advisory Group, LLC (Three-Sixty) and Founder and General Partner of Wavemaker Three-Sixty Health, LP (Wavemaker 360) venture fund. Founded in 2007 by Dr. Nackel, Three-Sixty consults with leading health systems, payers, physicians, medical technology companies, and other providers. Founded in 2018, Wavemaker 360 invests in early-stage health care companies in the value-based payment space. Dr. Nackel is a 25-year veteran of Ernst & Young where he advised health care companies in his role as a Global Managing Director of Health Care. Dr. Nackel also served as CEO of Ingenix Consulting (now Optum), a division of United Healthcare. Dr. Nackel served as a director of Mercury General Corporation (NYSE:MCY) from 2016 until 2018. During his career, Dr. Nackel has also served as a board member or chairman of several privately held start-ups and emerging companies, including Visual Health Solutions, Vitalacy, HealthTask, ConnectedHealth, NetStrike, and Sertan, Inc. He earned his bachelor's degree at Tufts University, master's degrees in public health and industrial engineering at the University of Missouri, and a Ph.D. in industrial engineering (health systems design) at the University of Missouri. He is a fellow of the American College of Healthcare Executives (FACHE) and the Healthcare Information and Management Systems Society (FHIMSS). He is a senior member of the Institute of Industrial Engineers (IIE). We believe that Dr. Nackel’s extensive experience as a consultant and an advisor to healthcare companies, his extensive board and management experience and his valuable leadership and management insights support the conclusion that he should serve as one of our directors.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 135,705
Long-Term Incentive Plans, USD --
All Other, USD 73,167
Fiscal Year Total, USD 208,872

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Roy Christensen

100,309

Christopher Christensen

1,838,660

Suzanne Snapper

1,337,400

Chad Keetch

1,129,070

Beverly Wittekind

838,271

Barry Port

1,486,700
As Of  31 Dec 2017